| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37K | -99.8% |
| R&D Expense | $141.3M | +45.5% |
| SG&A Expense | $46.6M | +27.6% |
| Operating Income | -$187.8M | -66.4% |
| Income Tax | $0 | — |
| Net Income | -$160.9M | -59.5% |
| EPS (Basic) | -$2.98 | -15.5% |
| EPS (Diluted) | -$2.98 | -15.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149.3M | -40.1% |
| Short-term Investments | $275.5M | +604.3% |
| Current Assets | $434.9M | +46.6% |
| Total Assets | $560.4M | +64.9% |
| Current Liabilities | $29.1M | +53.8% |
| Total Liabilities | $49.8M | +55.3% |
| Stockholders' Equity | $510.6M | +65.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$134.6M | -77.6% |
| Capital Expenditures | $3.8M | +36.6% |
| Investing Cash Flow | -$302.4M | -361.4% |
| Financing Cash Flow | $337.3M | +115.0% |
| Free Cash Flow | -$138.4M | -76.1% |